Faculty members in Penn Medicine's pulmonary division, led by Steven Albelda, MD, interact closely with faculty from thoracic surgery, oncology and pathology.
Other members of the group include Drs. Anil Vachani, Andrew Haas, Edmund Moon and Jeffrey Thompson from Pulmonary, Drs. Sunil Singhal and Evgeniy Eruslavnov from Thoracic Surgery, Dr. Corey Langer from Oncology, and Drs. Leslie Litzky and Charu Desponde from pathology. Research from this group is supported by NCI-funded Program Projects, a NIEHS Superfund Grant, NIH RO1 and KO8 grants, Industry, and Foundation support. The Abramson Cancer Center supports a Translational Center of Excellence in Lung Cancer Immunobiology and Immunotherapy.
Members of the group and their research interests include:
- Steve Albelda, MD
- Preclinical studies of immunogene therapy for lung cancer and mesothelioma
- Immune analysis of clinical trials using gene therapy or immunotherapy
- Understanding the lung cancer tumor microenvironment
- Precision Medicine
- Optimizing adoptive T cell transfer for the treatment of thoracic malignancies
- Andrew Haas, MD, PhD
- Clinical trials using gene therapy or immunotherapy to treat malignant mesothelioma and lung cancer
- Interventional bronchoscopy treatment of COPD
- Sunil Singhal, MD / Evgeniy Eruslanov, PhD
- Intraoperative imaging to detect residual or recurrent cancer
- Lung cancer microenvironment with a focus on myeloid cells
- Jeffrey Thompson, MD
- Understanding the lung cancer tumor microenvironment
- Development and validation of tissue and blood-based biomarkers for the early detection and prognostication of thoracic malignancies
- Precision Medicine
- Isolation and analysis of tumor-derived materials from peripheral blood
- Anil Vachani, MD
- Determination of markers to predict survival after lung cancer surgery
- Discovery of biomarkers for early detection of lung cancer
- Gene environment interactions in lung cancer
- Precision Medicine